Toll Free: 1-888-928-9744

NeoPharm Co., Ltd. - Product Pipeline Review - 2014

Published: Aug, 2014 | Pages: 31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

NeoPharm Co., Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'NeoPharm Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Neopharm Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Neopharm Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of NeoPharm Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of NeoPharm Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the NeoPharm Co., Ltd.'s pipeline products

Reasons to buy

- Evaluate NeoPharm Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of NeoPharm Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the NeoPharm Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of NeoPharm Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of NeoPharm Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of NeoPharm Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
NeoPharm Co., Ltd. Snapshot 5
NeoPharm Co., Ltd. Overview 5
Key Information 5
Key Facts 5
NeoPharm Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
NeoPharm Co., Ltd. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
NeoPharm Co., Ltd. - Pipeline Products Glance 11
NeoPharm Co., Ltd. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
NeoPharm Co., Ltd. - Drug Profiles 13
NPB-112 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
NPB-3 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
NPS-1 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
NPS-1034 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Protein for Allergies 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecule for Allergic Asthma 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
NPB-2 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
NPS-2 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
NPS-3 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
NPS-4 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
NeoPharm Co., Ltd. - Pipeline Analysis 24
NeoPharm Co., Ltd. - Pipeline Products by Target 24
NeoPharm Co., Ltd. - Pipeline Products by Route of Administration 25
NeoPharm Co., Ltd. - Pipeline Products by Molecule Type 26
NeoPharm Co., Ltd. - Pipeline Products by Mechanism of Action 27
NeoPharm Co., Ltd. - Company Statement 28
NeoPharm Co., Ltd. - Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31
List of Tables
NeoPharm Co., Ltd., Key Information 5
NeoPharm Co., Ltd., Key Facts 5
NeoPharm Co., Ltd. - Pipeline by Indication, 2014 8
NeoPharm Co., Ltd. - Pipeline by Stage of Development, 2014 9
NeoPharm Co., Ltd. - Monotherapy Products in Pipeline, 2014 10
NeoPharm Co., Ltd. - Preclinical, 2014 11
NeoPharm Co., Ltd. - Discovery, 2014 12
NeoPharm Co., Ltd. - Pipeline by Target, 2014 24
NeoPharm Co., Ltd. - Pipeline by Route of Administration, 2014 25
NeoPharm Co., Ltd. - Pipeline by Molecule Type, 2014 26
NeoPharm Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 27
NeoPharm Co., Ltd., Other Locations 29 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify